Advances and future directions in ROS1 fusion-positive lung cancer.
Boulanger MC, Schneider JL, Lin JJ.
Oncologist. 2024 Nov 4;29(11):943-956. doi: 10.1093/oncolo/oyae205.
The KMT2A recombinome of acute leukemias in 2023.
Meyer C, Larghero P, Almeida Lopes B, Burmeister T, Gröger D, Sutton R, Venn NC, Cazzaniga G, Corral Abascal L, Tsaur G, Fechina L, Emerenciano M, Pombo-de-Oliveira MS, Lund-Aho T, Lundán T, Montonen M, Juvonen V, Zuna J, Trka J, Ballerini P, Lapillonne H, Van der Velden VHJ, Sonneveld E, Delabesse E, de Matos RRC, Silva MLM, Bomken S, Katsibardi K, Keernik M, Grardel N, Mason J, Price R, Kim J, Eckert C, Lo Nigro L, Bueno C, Menendez P, Zur Stadt U, Gameiro P, Sedék L, Szczepański T, Bidet A, Marcu V, Shichrur K, Izraeli S, Madsen HO, Schäfer BW, Kubetzko S, Kim R, Clappier E, Trautmann H, Brüggemann M, Archer P, Hancock J, Alten J, Möricke A, Stanulla M, Lentes J, Bergmann AK, Strehl S, Köhrer S, Nebral K, Dworzak MN, Haas OA, Arfeuille C, Caye-Eude A, Cavé H, Marschalek R.
Leukemia. 2023 May;37(5):988-1005. doi: 10.1038/s41375-023-01877-1. Epub 2023 Apr 5.
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
Samy E, Wax S, Huard B, Hess H, Schneider P.
Int Rev Immunol. 2017 Jan 2;36(1):3-19. doi: 10.1080/08830185.2016.1276903.
TO THE EDITOR.
Schneider BJ, Sullivan W, Prather H, Smuck M, McCormick Z.
Spine (Phila Pa 1976). 2020 Apr 1;45(7):E412-E413. doi: 10.1097/BRS.0000000000003388.
Antibody Batch Cloning.
Ballmann R, Schneider KT, Roth KDR, Dübel S.
Methods Mol Biol. 2023;2702:411-417. doi: 10.1007/978-1-0716-3381-6_21.
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.
van Weelderen RE, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, De Moerloose B, Dworzak MN, Elitzur S, Fernández Navarro JM, Gamis A, Gerbing RB, Goemans BF, de Groot-Kruseman HA, Guest E, Ha SY, Hasle H, Kelaidi C, Lapillonne H, Leverger G, Locatelli F, Miyamura T, Norén-Nyström U, Polychronopoulou S, Rasche M, Rubnitz JE, Stary J, Tierens A, Tomizawa D, Zwaan CM, Kaspers GJL.
Blood Adv. 2024 Jun 25;8(12):3200-3213. doi: 10.1182/bloodadvances.2023011771.
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.
Windisch R, Soliman S, Hoffmann A, Chen-Wichmann L, Danese A, Vosberg S, Bravo J, Lutz S, Kellner C, Fischer A, Gebhard C, Redondo Monte E, Hartmann L, Schneider S, Beier F, Strobl CD, Weigert O, Peipp M, Schündeln M, Stricker SH, Rehli M, Bernhagen J, Humpe A, Klump H, Brendel C, Krause DS, Greif PA, Wichmann C.
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2312499121. doi: 10.1073/pnas.2312499121. Epub 2024 Jun 10.
Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Hoffmeister LM, Suttorp J, Walter C, Antoniou E, Behrens YL, Göhring G, Awada A, von Neuhoff N, Reinhardt D, Schneider M.
Leukemia. 2024 Mar;38(3):538-544. doi: 10.1038/s41375-023-02102-9. Epub 2023 Dec 12.
Formal Thought Disorders-Historical Roots.
Jerónimo J, Queirós T, Cheniaux E, Telles-Correia D.
Front Psychiatry. 2018 Nov 9;9:572. doi: 10.3389/fpsyt.2018.00572. eCollection 2018.
Genetically engineered fusion proteins for treatment of cancer.
Weidle UH, Schneider B, Georges G, Brinkmann U.
Cancer Genomics Proteomics. 2012 Nov;9(6):357-72.
